Upon publication of the first edition of Therapeutic Peptides and Proteins ten
years ago there were only 19 biotechology medicines on the market. Currently
there are more than 100, with at least 400 more in various stages of
development. That alone would be grounds for a new edition. Add to that the fact
that it is still difficult to find up-to-date, relevant information on protein
formulation and/or delivery systems and the need for a new edition is
self-evident. This second edition continues the tradition of providing a
ready-to-use reference of accurate information, tables, and illustrations. The
book begins with the basics of the origin of recombinant proteins,